Fed. Circ. Won't Revive Novartis Hemophilia Drug IP Suit
A divided appellate panel issued a precedential ruling holding that a Delaware federal court didn't err when it dismissed GI's suit and ruled that the two-way test used to determine if patents interfere with each other hadn't been met.
The majority affirmed “the district...
To view the full article, register now.